European National Pathology Congresses

Revolutionising precision oncology: new biomarker identification with 1-day NGS

Biomarker testing in precision oncology: a European revolution

Even in these hard times, our thought leaders virtually presented their experiences with our Oncomine™ NGS solutions in the most important European national pathology congresses. Have you missed the opportunity to join us in one of our satellite symposia during 2021?

Now you have the possibility to access all our on-demand content in local language and discover how NGS can be as fast and easy as IHC allowing your lab to test latest and established relevant biomarkers in a single day.

Choose the topic you are interested the most to learn more on:

The Promise of 1-Day Easy NGS

Discover how to deliver NGS results at the same time as other single-gene methods with the Ion Torrent™ Genexus™ System.

speaker-images-emea-local-events-Lopez

spain RNA-based next generation sequencing para la detección de fusiones

Prof. Fernando Lopez-Rios, Universidad CEU San Pablo, Spain

Watch Presentation

Download Slides

 

speaker-images-emea-local-events-Losa

spain Análisis de Secuenciación Masiva automatizada mediante Genexus en tumores sólidos

Prof. Xavier Hernandez Losa, Vall d'Hebron University Hospital, Spain

Watch Presentation

Download Slides

speaker-images-emea-local-events-Hummel

germany Zukünftige therapierelevante Veränderungen per NGS in nur einem Tag

Prof. Michael Hummel, Charité CCC, Germany

Watch Presentation

Download Slides

speaker-images-emea-local-events-Allen

uk The use of Genexus system and Oncomine™ Precision Assay as fast and sensitive NGS solution for solid tumour molecular characterisation

Dr. Hana Lango Allen, East Genomic Laboratory Hub, UK

Watch Presentation

Download Slides

speaker-images-emea-local-events-Warner

uk Verification of next generation sequencing in the pathology department Cork University Hospital

Dr. Reiltin Werner, Cork University Hospital, Ireland

Watch Presentation

Download Slides

speaker-images-emea-local-events-Destro

italy Utilizzo del Genexus per la profilazione molecorare dei tumori in NGS

Dr. Annarita Destro, Humanitas Research Hospital, Italy

Watch Presentation

Download Slides

Oncologist Perspective on Molecular Testing

Listen to European oncologists and learn from them how NGS based molecular characterisation of tumour samples will provide a rational and highly promising approach for guiding oncologists in treatment decision-making.

speaker-images-emea-local-events-Provencio

spain-1 Visión del Oncólogo de la Medicina de Precisión

Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain

Watch Presentation

Download Slides

speaker-images-emea-local-events-Provencio

uk Precision Medicine: Oncologist perspective on the impact of the molecular evaluation of solid tumour

Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain

Watch Presentation

Download Slides

speaker-images-emea-local-events-Passiglia

italy Il paradigma in evoluzione della medicina di precisione nel cancro del polmone La prospettiva dell'oncologo

Dr. Francesco Passiglia, University of Turin, Italy

Watch Presentation

Download Slides

One Size Does Not Fit All

Gain more detailed insights faster with the complete Oncomine solid tumour NGS workflow solution. Listen to our users and discover our broad assay menu from targeted to comprehensive genomic profiling, with the smallest sample input requirements in the industry. Learn from them how to analyse more samples and produce complete bioinformatic reports that drive key insights.

speaker-images-emea-local-events-Ruano

spain-1 Estudio molecular del cáncer de pulmón: De los métodos convencionales a la NGS

Dr. Yolanda Ruano Dominguez, Hospital 12 de Octubre, Spain

Watch Presentation

Download Slides

speaker-images-emea-local-events-Raineri

uk Clinical research on genomic profiling using the Oncomine™ Comprehensive Assay Plus

Dr. Ines Raineri, Institute for Pathology Medica AG, Switzerland

Watch Presentation

Download Slides

speaker-images-emea-local-events-Jung

germany Homologous Recombination Repair Deficiency HRD

Dr. Andreas Jung, University of Munich, Germany

Watch Presentation

Download Slides

Wild

germany RET als Tumormarker beim NSCLC und Schilddrüsenkarzinom

Prof. Dr. Peter Wild, Universitätsklinikum Frankfurt, Germany

Watch Presentation

Download Slides

Would you like to speak with a Thermo Fisher Scientific representative?
Click the button below to request contact.

request-contact-cta

 

For Research Use only. Not for use in diagnostic procedures.